Lithium Hydroxide → HCID 57672496, compound
Reaction equation
Cl[CH2:2][C:3]1[CH:4]=[CH:5][C:6]([C:18]([CH3:21])([CH3:20])[CH3:19])=[C:7]([C:9]2[CH:14]=[C:13]([O:15][CH3:16])[CH:12]=[CH:11][C:10]=2[F:17])[CH:8]=1.[OH:22][C:23]1[CH:28]=[CH:27][C:26]([CH2:29][CH:30]([CH3:36])[C:31]([O:33]CC)=[O:32])=[CH:25][CH:24]=1.C(=O)([O-])[O-].[Cs+].[Cs+].[OH-].[Li+]>CN(C=O)C.O>[F:17][C:10]1[CH:11]=[CH:12][C:13]([O:15][CH3:16])=[CH:14][C:9]=1[C:7]1[CH:8]=[C:3]([CH:4]=[CH:5][C:6]=1[C:18]([CH3:21])([CH3:20])[CH3:19])[CH2:2][O:22][C:23]1[CH:24]=[CH:25][C:26]([CH2:29][CH:30]([CH3:36])[C:31]([OH:33])=[O:32])=[CH:27][CH:28]=1Participants
7
Procedure
The reaction mixture of compound A (30.0 mg, 97.8 μmol), compound 12.3 (22.4 mg, 108 μmol) and cesium carbonate (38.2 mg, 117 μmol) in DMF (1.0 mL) was stirred at room temperature overnight. The resulting reaction mixture was treated with lithium hydroxide (23.4 mg, 978 μmol) in water (0.5 mL), and stirred at room temperature for 5 hours. The reaction mixture was purified by reverse phase preparative HPLC to give the title compound. MS ESI (neg.) m/e: 449 (M−H). 1H NMR (CD3CN) δ 7.61(d, 1H), 7.41(d, 1H), 7.11(d, 2H), 7.06(m, 2H), 6.93(m, 1H), 6.89(d, 2H), 6.81(d, 1H), 5.02(s, 2H), 3.77 (s, 3H), 2.86(dd, 1H), 2.63(m, 2H), 1.21(s, 9H), 1.09(d, 3H).
Workup
- customThe resulting reaction mixture
- stirringstirred at room temperature for 5 hours
- customThe reaction mixture was purified by reverse phase preparative HPLC
Sources & evidence
- ORD record
- ord-ef26f280882d4e66b14659ebd7c7d003
- Source dataset
- uspto-grants-2009_08
- Patent number
- US07572934B2
Reaction notes
Loading…